Binding levels of [3H]Ro5-4864, a ligand selective for peripheral-type benzodiazepine receptors, are substantially higher in homogenates of the olfactory bulb than in the rest of the brain. Among peripheral tissues evaluated, high levels of [3H]Ro5-4864 binding are found in the nasal epithelium. Drug displacement studies show that these binding sites are pharmacologically of the peripheral type. Their presence in the nasal epithelium and in the olfactory bulb can be demonstrated in several different mammalian species. Autoradiographic studies of murine nose reveal a bipolar staining pattern around the cell bodies of the olfactory receptor cells, suggesting the presence of peripheral-type benzodiazepine receptors on both processes of these bipolar neurons. In the brain a high density of [3H]Ro5-4864 binding sites occurs in the nerve fiber and glomerular layers of the olfactory bulb. Throughout the rest of the brain [3H]Ro5-4864-associated silver grains are diffusely distributed with intense staining over the choroid plexus and along the ependymal linings of the ventricles. Both the distribution and the ontogenic development of the peripheral-type benzodiazepine receptors differ from the central-type receptors. Intranasal irrigation with 5% ZnS04
Benzodiazepines are a class of anxiolytic and anticonvulsant drugs which interact with specific binding sites in the brain and which are thought to mediate their physiological effects by potentiating the binding of the inhibitory neurotransmitter GABA to its receptor (Braestrup and Squires, 1977; Miihler and Okada, 1977; Tallman et al., 1978 Tallman et al., , 1980 Wastek et al., 1978; Olson, 1981) . A good correlation exists between the anxiolytic potencies of various benzodiazepines and their relative affinities for the benzodiazepine receptor sites in the brain (reviewed by Tallman et al., 1980) . In addition, benzodiazepine binding sites have been identified in the kidney and other peripheral tissues (Braestrup and Squires, 1977; Regan et al., 1981) . These "peripheral" benzodiazepine binding sites differ significantly from the "central" benzodiazepine receptors in their pharmacological properties. Benzodiazepines which are potent anxiolytics and which bind with high affinity to the central receptors, such as clonazepam, have negligible potency for the peripheral benzodiazepine binding sites (Braestrup and Squires, 1977; Miihler and Okada, 1977; Tallman et al., 1980; Schoemaker et al., 1981 Schoemaker et al., , 1982a Schoemaker et al., , 1983 Marangos et al., 1982) . Furthermore, in contrast to the central receptors, the binding of benzodiazepines to peripheral receptors is not affected by GABA or chloride ions (Marangos et al., 1982; Schoemaker et al., 1982) .
The benzodiazepine Ro5-4864, which is not anxiolytic, has high affinity for the peripheral receptor sites but negligible affinity for the central benzodiazepine binding site (Braestrup and Squires, 1977) .
[3H]Ro5-4864 can be used to label peripheral-type benzodiazepine receptor sites in the brain as well as in peripheral tissues (Schoe-maker et al., 1981 (Schoe-maker et al., , 1982a (Schoe-maker et al., , 1983 Marangos et al., 1982) . A preliminary autoradiographic study revealed a high density of [3H]Ro5-4864 binding sites in the olfactory bulb and a diffuse binding throughout the rest of the brain (Richards et al., 1982) . Schoemaker et al. (1982b) demonstrated a significant increase in the number of [3H]Ro5-4864 binding sites in the putamen of patients with Huntington's disease and in brains of rats following intrastriatal injections with kainic acid. Since the increase in [3H]Ro5-4864 binding sites paralleled a process of glial proliferation, these authors proposed that [3H] Ro5-4864 binding sites in the brain may be localized to glia.
In the present study we provide evidence that [3H] Ro5-4864 binding observed in the olfactory bulb is localized to olfactory nerves which originate in the nose and terminate in the glomerular layer of the olfactory bulb. Furthermore, we present data from binding experiments and autoradiographic studies which demonstrate a high density of peripheral-type benzodiazepine receptors on the processes of olfactory receptor cells in the nasal epithelium.
Materials and Methods
Preparation of membranes. Male (150 to 200 gm) Sprague-Dawley rats or male (30 to 35 gm) ICR mice were obtained from Harlan Sprague-Dawley (Walkersville, MD) and Blue Spruce Farms (Altamont, NY), respectively. The animals were sacrificed by cervical dislocation and decapitation, and the brains (without the olfactory bulbs), olfactory bulbs, and peripheral organs were homogenized in ice-cold 50 mM Tris buffer, pH 7.7, with a Brinkmann Polytron PT-10 at medium speed for 15 sec. Nasal epithelium was obtained while still attached to the septum and turbinate cartilages. The bone and cartilage were crushed with a razor blade, and the nasal epithelium was detached mechanically by vigorous vortexing for 1 min in 50 mM Tris buffer, pH 7.7. The cartilage and bone were allowed to settle, and the suspension was carefully decanted. The bones were once again subjected to mechanical agitation in buffer for 1 min, and the resulting suspension was combined with the first one. The pooled tissue suspension was homogenized with a Polytron at medium speed for 15 sec. All homogenates were centrifuged at 50,000 x g for 10 min, and the pellets were washed twice by homogenization with the Polytron in 50 mM Tris buffer, pH 7.7. Final pellets were suspended in 50 mM Tris buffer, pH 7.7, and assayed for protein content using the assay of Lowry et al. (1951) with bovine serum albumin as standard. Prior to use, suspensions of nasal membranes were sometimes filtered through four layers of sterile gauze to remove remaining fragments of cartilage.
Receptor binding assays. Each assay contained 0.1 ml of radioactive ligand, 0.1 ml of displacing ligand, and 1.8 ml of membrane suspension containing 0.1 to 0.4 mg of protein in 50 mM Tris buffer, pH 7.7. The tubes were incubated in an ice water bath for 1 hr. The assays were terminated by vacuum filtration on Whatman GF/B filters followed by one wash with 10 ml of ice-cold buffer. The filters were extracted in Formula 947 scintillation cocktail (New England Nuclear), and radioactivity was measured in a scintillation counter at 47% efficiency. Intranasal irrigation with ZnS04 and assessment of anosmia. Unanesthetized mice were held on their backs and droplets of a 5% ZnSOl solution were slowly deposited one by one from a Hamilton syringe on top of both nostrils. A total volume of 80 to 100 ~1 of ZnSO, solution was administered to each mouse.
ZnS04-treated and age-matched control mice were tested for anosmia essentially as described by Harding et al. (1978) . The mice were subjected to overnight food deprivation and tested for their ability to locate a buried food pellet. Each mouse was individually placed in a plastic box (28 X 17 X 12 cm) containing a layer (approximately 1 cm) of clean bedding (Beta-Chip, Hardwood Laboratory Bedding, Northeastern Products Corp. Warrensburg, NY). The box contained a single pellet of mouse chow (2 X 1 X 0.5 cm; Charles River Laboratories, Wilmington, MA) buried just below the bedding in the center of the cage. Mice were allowed 5 min to locate the food pellet. The test ended when the mouse held the pellet in its front paws. Ninety-two percent (n = 67) of untreated control mice were able to locate the food pellet within the allocated time, and 100% of these mice were successful when tested a second time. For the second trial the food pellet was moved to a location 7 cm forward of the center of the cage to prevent the possibility of food localization by learned behavior rather than through smell. Only mice which had demonstrated the ability to localize the food pellet twice were used for ZnSOl lesions. Mice which failed to localize the food pellet after two trials were considered anosmic. Usually these mice would 
Results

Identification of peripheral-type benzodiazepine receptors in nasal epithelium
Binding studies. Among various rat tissues examined, the highest levels of [3H]Ro5-4864 binding are detected in the nasal epithelium (BmaX = 4 to 5 nmol/gm of protein), the testis, and the kidney, with somewhat lower receptor densities in the lung (Table I ). The lowest density of peripheral-type benzodiazepine receptors is found in the brain (without the olfactory bulbs), with [3H]Ro5-4864 binding levels only about one-fortieth of the nasal epithelium. Binding in the olfactory bulb is approximately 7 times higher than in the rest of the brain.
Properties of [3H]Ro5-4864 binding sites are similar in the various tissues. The dissociation constant is essentially the same in the brain, olfactory bulb, nasal epithelium, and kidney, about 1 to 2 nM ( Fig. 1 ). In addition, several benzodiazepines and related agents compete for the binding sites in brain, kidney, olfactory bulb, and nasal epithelium, with similar potencies and a pharmac,ological pattern characteristic of peripheral-type receptors (Fig. 2) . Of the drugs examined, only diazepam and flunitrazepam as well as Ro5-4864 are effective displacers. The potent anxiolytic clonazepam and the potent benzodiazepine antagonist [3H]Ro15-1788 (Hunkeler et al., 1981) are ineffective at the peripheral-type benzodiazepine binding site (Fig. 2) . GABA (0.1 mM) lowers the KD of [3H]methylclonazepam for binding to brain membranes by 30%, but it has no effect on the binding of [3H]Ro5-4864, in agreement with previous reports (Marangos et al., 1982; Schoemaker et al., 1983 ; data not shown).
A high density of peripheral-type benzodiazepine receptors in the nasal epithelium is not species specific for (Fig.  4) . No grains are evident over the cell bodies of the olfactory receptor cells, the turbinate cartilages and the septum, and the subepithelial Bowman's glands.
The olfactory receptor cells are bipolar neurons which extend a short process into the mucus layer, which lines the lumen of the nasal cavity, and a long axon which proceeds through the cribriform plate and into the olfactory bulb, the site of the first synaptic relay. The bipolar pattern of grains observed by autoradiography suggests the presence of peripheral-type benzodiazepine receptors on both the short process and the long axon of the olfactory receptor cells but not on the cell bodies. Peripheral-type benzodiazepine receptors in the brain Autoradiographic localization of [3H]Ro5-4864 binding sites in sagittal sections of the brain reveals a diffuse presence of peripheral-type benzodiazepine receptors throughout the brain (Fig. 5A) . Particularly high deposits of silver grains are observed along the ependymal linings of the lateral, third, and fourth ventricles and over the choroid plexus. In addition, a well defined band of silver grains is apparent along the rim of the olfactory bulb.
At higher magnification it is evident that the [3H]Ro5-4864 binding sites in the olfactory bulb are localized in the nerve fiber layer and the adjacent glomerular layer (Fig. 6, A and B) . The glomerular layer represents the termination point of the primary olfactory nerves which synapse here with mitral cells and various interneuronal cell types (for a review, see Shepherd, 1979) .
This localization of the peripheral-type benzodiazepine receptors contrasts sharply with the distribution of central-type benzodiazepine receptors in the brain. As reported previously (Young and Kuhar, 1980) , high densities of central benzodiazepine receptors occur throughout the cortex, in the molecular layer of the cerebellum, the dentate gyrus and the hippocampus, in the inferior Ro5-4864 to membranes of various tissues from the rat. Each data point is derived from triplicate measurements of total and nonspecific counts per minute retained on the filters. Each measurement is within 5% standard error. The best fitted line through the points was calculated by linear regression analysis. Correlation coefficients for the brain (without olfactory bulbs), olfactory bulb, nasal epithelium, and kidney are 0.985, 0.924, 0.949, and 0.978, respectively. The Scatchard plot for the brain is included merely for comparison to illustrate the striking differences in relative concentrations of peripheral-type benzodiazepine receptors in the brain, olfactory bulb, and nasal epithelium. Data points for the brain have been omitted since on this scale they would obscure the line. and superior colliculi, and as a high-density band in the main olfactory bulb and the accessory olfactory bulb (Fig. 5) . However, in contrast to the peripheral-type benzodiazepine receptors, central benzodiazepine receptors appear to be concentrated in the external plexiform layer (Fig. 6, A and C) .
In addition to differences in their localization, peripheral-type and central-type benzodiazepine receptors differ in the time course of their appearance during the ontogeny of the olfactory bulb. ["H]Ro5-4864 binding can be detected in the fetal olfactory bulb at near-adult levels at day 19 of gestation, whereas the central-type benzodiazepine receptors appear in the early postnatal period (Fig. 7) . In addition, peripheral-type benzodiazepine receptors occur at levels similar to those of adult brain in homogenates of 16-day-old whole embryonic heads, whereas central-type benzodiazepine receptors at this time are undetectable (data not shown). documented to cause extensive destruction of the olfactory epithelium in the mouse (Margolis et al., 1974; Matulionis, 1975 Matulionis, , 1976 Harding et al., 1978) , as well as in several other species (Schultz, 1960; Mulvaney and Heist, 1971; Adameik et al., 1980; Cancalon, 1982) , and leads to degeneration of the nerve fiber and glomerular layers within the olfactory bulb (Harding et al., 1978) . We measured the binding of [3H]Ro5-4864 and [3H] methylclonazepam in membrane homogenates of the olfactory bulb, the rest of the brain, and the kidney 16 days after a single bilateral irrigation of the nose with 5% ZnS04. By this time 6 of 17 lesioned animals had regained their ability to smell as judged by their performance in the food localization test after overnight starvation. Only animals that were anosmic at this time were considered successfully lesioned and used for binding studies. The olfactory bulbs from these animals showed a reduction of 36 f 7% (n = 10) in total membrane Vol. 4, No. 2, Feb. 1984 cat i :.: ,. id '.," of the receptors in the nasal epithelium were 2.01 +-0.20 nM for mouse, 1.27 + 0.13 nM for rat, 1.30 f 13 nM for guinea pig, 7.8 + 2.3 nM for cat, and 6.5 + 0.7 nM for dog. Hartley strain guinea pigs were obtained from Buckberg Laboratories (Tomkin Cove, NY) and were sacrificed by decapitation. Cats and dogs were obtained from local physiology laboratories and were sacrificed by lethal injection with pentobarbital.
Membranes of tissues from these animals were washed at least six times with 50 vol of 50 mM Tris buffer, pH 7.7, after homogenization to ensure complete removal of any membrane-bound pentobarbital prior to the binding assay.
protein content as compared to the age-matched controls. The ZnSOr lesion elicited a 50% decline of (Table II) . Thus, our results suggest that a major portion of the [3H]Ro5-4864 binding sites which are present in the olfactory bulb is located on olfactory nerves which are destroyed following the treatment with Z&O.+ Discussion In the present study we have found that peripheraltype benzodiazepine receptors labeled by [3H]Ro5-4864 appear to be associated with olfactory neurons in the nose and in the olfactory bulb. This notion is supported Peripheral-type benzodiazepine receptors can be detected in the fetal olfactory bulb at least 4 days before birth. By this time the main afferent olfactory pathway which involves the synaptic relay between olfactory neurons from the nasal epithelium and mitral cells in the olfactory bulb is intact (Gesteland et al., 1982) . The localization of [3H]Ro5-4864 binding sites in the nerve fiber and glomerular layers of the olfactory bulb and their prenatal presence in the olfactory bulb are consistent with their localization on the axons of olfactory receptor cells, which terminate in the glomerular layer and which are well developed by day 16 of gestation (Gesteland et al., 1982; Bayer, 1983) . The complex interneuronal circuitry which modulates the relay of primary olfactory information originates largely in the first postnatal weeks (Mair et al., 1982; Bayer, 1983) . The localization of central-type benzodiazepine receptors in the external plexiform layer of the olfactory bulb together with their postnatal development suggests that these receptors may be present on interneurons.
The function of the peripheral-type benzodiazepine receptor is still unknown.
Recently, Ro5-4864 at dosages of -30 mg/kg has been reported to have some anxiogenic activity and to elicit seizures in mice and rats (File and Lister, 1983) . This rather weak anxiogenic activity does not appear to correlate well with the high affinity of Ro5-4864 for the peripheral-type benzodiazepine binding site. Moreover,
[3H]Ro5-4864-induced seizures do not shed light on what the role might be of peripheral-type benzodiazepine receptors on olfactory nerves and in peripheral tissues.
Several hypotheses can be considered regarding the role of peripheral-type benzodiazepine receptors on olfactory nerves. It is conceivable that peripheral-type benzodiazepine receptors may modulate odorant recognition, the firing rate of the olfactory neurons, or neurotransmitter release. Alternatively, peripheral-type benzodiazepine receptors may play a role in the growth and differentiation of the olfactory receptor cells. The olfactory epithelium has a unique regenerative capacity, and olfactory receptor cells are known to turn over rapidly throughout the life span of the animal. The halflife time of olfactory neurons in the mouse is 4 to 6 weeks (Moulton, 1974) . New receptor cells are continuously generated from neurogenic stem cells in the base of the olfactory epithelium (Moulton et al., 1970; Moulton, 1974; Matulionis, 1975, and 1976; Harding et alJ977; Cancalon, 1982) . Perhaps peripheral-type benzodiazepine receptors play a role in directing axonal growth and cell differentiation of the olfactory neurons.The observation that Ro5-4864, acting through a peripheral-type benzodiazepine receptor site, promotes the growth of melanoma cells in culture and enhances the onset of melanin synthesis (Matthew et al., 1981) lends some support to this hypothesis.
